https://sparknewswire.com/newsfeed/the-daily-biotech-pulse-fda-decision-on-biogen-alzheimers-drug-due-in-january-fda-reviews-roches-lymphoma-candidate-rare-pediatric-tag-for-kazias-pediatric-brain-cancer-candidate/
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer’s Drug Due In January, FDA Reviews Roche’s Lymphoma Candidate, Rare Pediatric Tag For Kazia’s Pediatric Brain Cancer Candidate